Press Releases

• 1-year Event Free Survival (EFS) of 32.5% vs. 20% 1-year EFS for comparator
• Interim 1-year and 18-month Overall Survival (OS) of 90.4%
• 0 Grade 3, 4 or 5 Treatment-related Adverse Events (AEs)
• 41 patient trial fully enrolled
• Primary endpoint 12-month EFS data and interim co-primary endpoint 12-month OS data to be released in the fourth quarter of 2024
• No novel therapeutic interventions for resected, recurrent osteosarcoma in 40+years

ROCKVILLE,... (continue reading...)

AUSTIN, Texas, June 3, 2024 /PRNewswire/ -- In a major advance towards the future of U.S. joint and coalition partner military interoperability, Ultra Intelligence & Communications (Ultra I&C) is proud to announce its successful participation in the Federated Mission Networking (FMN) Coalition Interoperability Assurance and Validation (CIAV) Joint Command and Control Assessment (JC2A) in support of the U.S. Marine Corps' contribution to Combined Joint All Domain... (continue reading...)

PASADENA, Calif., June 3, 2024 /PRNewswire/ -- Pacific Oaks College & Children's School, a national leader in early childhood education, has appointed Breeda McGrath, Ph.D., as its new president, effective July 1, 2024. Dr. McGrath brings over 20 years of experience in higher education leadership and an extensive background in school psychology to the role, making her well suited to lead Pacific Oaks, a diverse community that educates students at all stages of the... (continue reading...)

AUSTIN, Texas--(BUSINESS WIRE)-- Presidio Investors, a leading investment firm specializing in high-growth companies, is pleased to announce the appointment of Susan Michaels as Operating Partner, effective immediately. Susan will leverage her extensive experience to drive growth and strategic direction at Presidio.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240603727836/en/

Susan Michaels (Photo:... (continue reading...)

ANAHEIM, Calif. , June 3, 2024 /PRNewswire/ -- Evosep, a leader in the field of proteomics, is proud to announce several significant advancements in scalable proteomics workflows at the ASMS 2024 conference in Anaheim. These innovations underline Evosep's commitment to enhancing the efficiency and accessibility of proteomics as a toolbox, specifically targeting the acceleration of the drug discovery process and bridging translational research to proteomics-based... (continue reading...)